drugset / Trial / NCT01605201

Tissue Engineered Nasal Cartilage for Regeneration of Articular Cartilage

NCT01605201 ↗

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the safety and feasibility of implanting an engineered cartilage graft obtained by culturing expanded autologous nasal chondrocytes within a collagen type I/III membrane into the cartilage defect on the femoral condyle and/or trochlea of the knee after a traumatic injury.

Timeline

Start
2012-08-29
Primary completion
2018-08-15
Completion
2018-08-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Tissue engineered cartilage graft Cell therapy — —